October 02, 2020
Specifically, the Business Group supported CMS efforts to
- Refine the Medicare ACO program to to achieve better health outcomes for beneficiaries at reduced costs
- Increase access to health services provided via telehealth both during the COVID-19 public health emergency (PHE) and beyond
- Steer the delivery system via changes to payment rules that seek to provide increased flexibility for telehealth in the supervision of Non-Physician Providers (NPPs)
- Increase the relative weights to determine payments for office/outpatient evaluation and management services.
- Address the opioid crisis by expanding the list of drugs that CMS will cover for Opioid Use Disorder (OUD) to include opioid antagonist medications drugs, such as Naloxone.
Comments to CMS on a 2020 Proposed Rule Physician Fee Schedule, ACOs, Part B Payment Policies and Others
More Topics
Policy & Advocacy Payment & Delivery ReformMore in Policy & Advocacy